A German court has issued a preliminary injunction against MegaGen and its CEO, Dr Kwang Bum Park, ordering them to desist from promoting defamatory remarks about Straumann.
The remarks were published on Wednesday in an interview with 'IDS Today', which was distributed at the world's largest dental trade fair, currently taking place in Cologne Germany. In the interview Dr Park made defamatory remarks concerning Straumann's approach to ethical business, customer satisfaction, product development and patient outcomes. Failure to comply with the preliminary injunction in Germany could result in fines of up to EUR 250 000.
Marco Gadola, CEO of the Straumann Group commented: "We want to emphasize that Straumann will take strong action to protect its reputation from malicious slander that MegaGen may spread. Straumann invested in MegaGen in good faith and faithfully complied with the procedural and legal process throughout the partnership."
The preliminary injunction is not a final ruling. It remains open whether or not the proceedings continue or MegaGen and Dr Kwang Bum Park accept the injunction as a final decision.
The Straumann Group (SIX: STMN) is a global leader in tooth replacement solutions that restore smiles and confidence. It unites global and international brands that stand for excellence, innovation and quality in tooth replacement and esthetics, including Straumann, Instradent, Neodent, and Medentika, etkon and other fully/partly owned companies and partners.
In collaboration with leading clinics, institutes and universities, the Group researches, develops, manufactures and supplies dental implants, instruments, CADCAM prosthetics, biomaterials and digital solutions for use in tooth replacement and restoration or to prevent tooth loss.
Headquartered in Basel, Switzerland, the Group employs 3800 people worldwide and its products, solutions and services are available in more than 100 countries through a broad network of distribution subsidiaries and partners.